Who owns Diamedica Therapeutics Inc?
- Ticker: DMAC
- CUSIP Number: 25253x207
Tip: Access positions for across all investors
Analyze quarterly positions in Diamedica Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Diamedica Therapeutics stock
Who bought or sold Diamedica Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Omega Advisors | 876k | $2.3M | 0% | Sep 2023 |
|
Vanguard Group | 802k | $2.3M | 2% | Dec 2023 |
|
Paragon Associates & Paragon Associates Ii Joint Venture | 500k | $1.4M | 6% | Dec 2023 |
|
Altium Capital Management | 496k | $1.3M | 100% | Sep 2023 |
|
Bleichroeder | 222k | $631k | 0% | Dec 2023 |
|
Geode Capital Management | 219k | $565k | 18% | Sep 2023 |
|
Eudaimonia Asset Management | 213k | $548k | -21% | Sep 2023 |
|
Jacob Asset Management of New York | 169k | $435k | -15% | Sep 2023 |
|
First Manhattan | 115k | $296k | -8% | Sep 2023 |
|
Aristides Capital | 106k | $274k | 100% | Sep 2023 |
|
BlackRock | 102k | $263k | 41% | Sep 2023 |
|
Morgan Stanley | 94k | $242k | 64% | Sep 2023 |
|
Northern Trust | 90k | $231k | 9% | Sep 2023 |
|
State Street Corporation | 67k | $172k | 0% | Sep 2023 |
|
Catalyst Financial Partners | 36k | $103k | 0% | Dec 2023 |
|
Bank of New York Mellon | 34k | $97k | -1% | Dec 2023 |
|
Millennium Management | 29k | $82k | 1% | Dec 2023 |
|
Citadel Advisors | 26k | $74k | 56% | Dec 2023 |
|
Jane Street | 24k | $68k | 100% | Dec 2023 |
|
Stonebridge Capital Advisors | 20k | $57k | 0% | Dec 2023 |
|
Dimensional Fund Advisors | 17k | $48k | 0% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 14k | $40k | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 13k | $38k | 0% | Dec 2023 |
|
H D Vest Advisory Services | 13k | $36k | 100% | Dec 2023 |
|
Massmutual Trust | 4.8k | $14k | 0% | Dec 2023 |
|
Us Bancorp | 4.3k | $12k | 0% | Dec 2023 |
|
Naples Money Management | 3.9k | $11k | 100% | Dec 2023 |
|
Tower Research Capital | 3.8k | $9.7k | -40% | Sep 2023 |
|
Royal Bank of Canada | 1.1k | $3.9k | 34% | Dec 2023 |
|
TD Waterhouse Canada | 1.1k | $4.0k | -32% | Dec 2023 |
|
Advisor Group Holdings | 1.0k | $2.8k | 0% | Dec 2023 |
|
Legend Financial Advisors | 1.0k | $2.8k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 564.00 | $1.6k | 2156% | Dec 2023 |
|
Simplex Trading | 481.00 | $999.999000 | -53% | Dec 2023 |
|
Wells Fargo & Company | 172.00 | $487.998400 | 6% | Dec 2023 |
|
Toronto-Dominion Bank | 24.00 | $61.999200 | 0% | Sep 2023 |
|
Bank of America Corporation | 15.00 | $43.000500 | 100% | Dec 2023 |
|
Who sold out of Diamedica Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Susquehanna International | Jun 2023 | 27k | $117k |
Marshall Wace | Sep 2023 | 27k | $69k |
Wolverine Trading | Sep 2023 | 21k | $55k |
UBS Group | Sep 2023 | 84.00 | $216.997200 |